Clinical trials
Phase 2 Graves Ophthalmopathy trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2019 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Immunovant Sciences GmbH | 1 |
| Ipsen | 1 |
| Lassen Therapeutics Inc. | 1 |
| Tourmaline Bio, Inc., a Novartis Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Ophthalmopathy | 5 |
| Exophthalmos | 2 |
| Eye Diseases | 2 |
| Endocrine System Diseases | 1 |
| Graves Disease | 1 |
| Hyperthyroidism | 1 |
| Orbital Diseases | 1 |
| Thyroid Diseases | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.